Benitec Biopharma Limited Capex/Depreciation

Capex/Depreciation of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending June 30, 2022 was -2.17 (a -Infinity% decrease compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by -Infinity%
  • Annual Capex/Depreciation for 2022 was -0.08 (a -91.87% decrease from previous year)
  • Annual Capex/Depreciation for 2021 was -0.96 (a -Infinity% decrease from previous year)
  • Annual Capex/Depreciation for 2021 was 0.0 (a -100.0% decrease from previous year)
  • Twelve month Capex/Depreciation ending June 30, 2022 was -0.18 (a -Infinity% decrease compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -Infinity% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-0.18 0.0 0.0 0.0
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of Benitec Biopharma Limited

Most recent Capex/Depreciationof BNTC including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of Benitec Biopharma Limited

Benitec Biopharma Limited Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -2.17 0.0 -0.08
2021 0.0 0.0 1.43 -0.12 -0.96
2020 -2.6 -3.84 -0.33 -0.01 -0.49
2019 -0.84 0.02 -2.53
2018 -0.42
2017 0.0 0.0
2016 0.0 -0.48 0.0 -1.18
2015 0.0 -5.25 -5.21
2014 0.0 -2.0 -2.52
2013 -0.33 -0.33

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology